Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 3/2008

01.03.2008 | Original Article

Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET(/CT) systems

verfasst von: Walter Jentzen, Reiner Weise, Jürgen Kupferschläger, Lutz Freudenberg, Wolfgang Brandau, Ronald Bares, Wolfgang Burchert, Andreas Bockisch

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study evaluated the absolute quantification of iodine-124 (124I) activity concentration with respect to the use of this isotope for dosimetry before therapies with 131I or 131I-labeled radiotherapeuticals. The recovery coefficients of positron emission tomography(/computed tomography) PET(/CT) systems using 124I were determined using phantoms and then validated under typical conditions observed in differentiated thyroid cancer (DTC) patients.

Methods

Transversal spatial resolution and recovery measurements with 124I and with fluorine-18 (18F) as the reference were performed using isotope-containing line sources embedded in water and six isotope-containing spheres 9.7 to 37.0 mm in diameter placed in water-containing body and cylinder phantoms. The cylinder phantom spheres were filled with 18F only. Measurements in two-dimensional (2D) and three-dimensional (3D) modes were performed using both stand-alone PET (EXACT HR+) and combined PET/CT (BIOGRAPH EMOTION DUO) systems. Recovery comparison measurements were additionally performed on a GE ADVANCE PET system using the cylinder phantom. The recovery coefficients were directly determined using the activity concentration of circular regions of interest divided by the prepared activity concentration determined by the dose calibrator. The recovery correction method was validated using three consecutive scans of the body phantom under our 124I PET(/CT) protocol for DTC patients.

Results

Compared with that of 18F, transversal spatial resolution of 124I was slightly, but statistically significantly degraded (7.4 mm vs. 8.3 mm, P<0.002). Using the body phantom, recovery was lower for 124I than for 18F in both 2D and 3D modes. The 124I recovery coefficient of the largest sphere was significantly higher in 2D than in 3D mode (81% vs. 75%, P=0.03). Remarkably, the 18F recovery coefficient for the largest sphere significantly deviated from unity (range of 87%–93%, P<0.004) for all scanners but the GE ADVANCE. The maximum range of inaccuracy of the measured 124I activity concentration under in vivo conditions after applying partial volume correction was ±10% for spheres ≥12.6 mm in diameter.

Conclusions

Recovery correction is mandatory for 124I PET quantification, even for large structures. To ensure accurate dosimetry, thorough absolute recovery measurements must be individually established for the particular PET scanner and radionuclide to be used.
Literatur
1.
Zurück zum Zitat Erdi YE, Macapinlac H, Larson SM, Erdi AK, Yeung H, Furhang EE, et al. Radiation dose assessment for I-131 therapy of thyroid cancer using I-124 PET imaging. Clin Positron Imaging 1999;2:41–6.PubMedCrossRef Erdi YE, Macapinlac H, Larson SM, Erdi AK, Yeung H, Furhang EE, et al. Radiation dose assessment for I-131 therapy of thyroid cancer using I-124 PET imaging. Clin Positron Imaging 1999;2:41–6.PubMedCrossRef
2.
Zurück zum Zitat Eschmann SM, Reischl G, Bilger K, Kupferschläger J, Thelen MH, Dohmen BM, et al. Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET. Eur J Nucl Med 2002;29:760–7.CrossRef Eschmann SM, Reischl G, Bilger K, Kupferschläger J, Thelen MH, Dohmen BM, et al. Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET. Eur J Nucl Med 2002;29:760–7.CrossRef
3.
Zurück zum Zitat Sgouros G, Kolbert KS, Sheikh A, Pentlow KS, Mun EF, Barth A, et al. Patient-specific dosimetry for I-131 thyroid cancer therapy using I-124 PET and 3-dimensional-internal dosimetry (3D-ID) software. J Nucl Med 2004;45:1366–72.PubMed Sgouros G, Kolbert KS, Sheikh A, Pentlow KS, Mun EF, Barth A, et al. Patient-specific dosimetry for I-131 thyroid cancer therapy using I-124 PET and 3-dimensional-internal dosimetry (3D-ID) software. J Nucl Med 2004;45:1366–72.PubMed
4.
Zurück zum Zitat Freudenberg LS, Bockisch A, Jentzen W. Iodine-124 PET dosimetry and PET/CT imaging in differentiated thyroid cancer. In: Biersack HJ, Grünwald F, editors. Thyroid cancer. Heidelberg - New York: Springer Verlag, 2005. 127–38.CrossRef Freudenberg LS, Bockisch A, Jentzen W. Iodine-124 PET dosimetry and PET/CT imaging in differentiated thyroid cancer. In: Biersack HJ, Grünwald F, editors. Thyroid cancer. Heidelberg - New York: Springer Verlag, 2005. 127–38.CrossRef
5.
Zurück zum Zitat Bockisch A, Freudenberg L, Rosenbaum S, Jentzen W. I-124 in PET imaging: impact on quantification, radiopharmaceutical development and distribution. Eur J Nucl Med Mol Imaging 2006;33:1247–8.PubMedCrossRef Bockisch A, Freudenberg L, Rosenbaum S, Jentzen W. I-124 in PET imaging: impact on quantification, radiopharmaceutical development and distribution. Eur J Nucl Med Mol Imaging 2006;33:1247–8.PubMedCrossRef
6.
Zurück zum Zitat Freudenberg L, Jentzen W, Görges R, Petrich T, Marlowe RJ, Knust J, et al. I-124 PET dosimetry in advance differentiated cancer. Nuklearmedizin 2007;46:121–8.PubMed Freudenberg L, Jentzen W, Görges R, Petrich T, Marlowe RJ, Knust J, et al. I-124 PET dosimetry in advance differentiated cancer. Nuklearmedizin 2007;46:121–8.PubMed
7.
Zurück zum Zitat Hoffmann EJ, Huang SC, Phelps ME. Quantitation in positron emission tomography: 1. Effect of object size. J Comput Assist Tomogr 1979;3:299–308.CrossRef Hoffmann EJ, Huang SC, Phelps ME. Quantitation in positron emission tomography: 1. Effect of object size. J Comput Assist Tomogr 1979;3:299–308.CrossRef
8.
Zurück zum Zitat Kessler RM, Ellis JT Jr, Eden M. Analysis of emission tomographic scan data: limitations imposed by resolution and background. J Comput Assist Tomogr 1984;8:514–22.PubMedCrossRef Kessler RM, Ellis JT Jr, Eden M. Analysis of emission tomographic scan data: limitations imposed by resolution and background. J Comput Assist Tomogr 1984;8:514–22.PubMedCrossRef
9.
Zurück zum Zitat Geworski L, Knoop BO, Levi de Cabrejas M, Knapp WH, Munz DL. Recovery correction for quantification in emission tomography: a feasibility study. Eur J Nucl Med 2000;27:161–9.PubMedCrossRef Geworski L, Knoop BO, Levi de Cabrejas M, Knapp WH, Munz DL. Recovery correction for quantification in emission tomography: a feasibility study. Eur J Nucl Med 2000;27:161–9.PubMedCrossRef
10.
Zurück zum Zitat Beattie BJ, Finn RD, Rowland DJ, Pentlow KS. Quantitative imaging of bromine-76 and yttrium-86 with PET: a method for the removal of spurious activity introduced by cascade gamma rays. Med Phys 2003;30:2410–23.PubMedCrossRef Beattie BJ, Finn RD, Rowland DJ, Pentlow KS. Quantitative imaging of bromine-76 and yttrium-86 with PET: a method for the removal of spurious activity introduced by cascade gamma rays. Med Phys 2003;30:2410–23.PubMedCrossRef
11.
Zurück zum Zitat Herzog H, Tellmann L, Qaim SM, Spellberg S, Schmid A, Coenen HH. PET quantitation and imaging of the non-pure positron-emitting iodine isotope I-124. Appl Radiat Isot 2002;56:673–9.PubMedCrossRef Herzog H, Tellmann L, Qaim SM, Spellberg S, Schmid A, Coenen HH. PET quantitation and imaging of the non-pure positron-emitting iodine isotope I-124. Appl Radiat Isot 2002;56:673–9.PubMedCrossRef
12.
Zurück zum Zitat Pentlow KS, Graham MC, Lambrecht RM, Cheung NK, Larson SM. Quantitative imaging of I-124 using positron emission tomography with applications to radioimmunodiagnosis and radioimmunotherapy. Med Phys 1991;18:357–66.PubMedCrossRef Pentlow KS, Graham MC, Lambrecht RM, Cheung NK, Larson SM. Quantitative imaging of I-124 using positron emission tomography with applications to radioimmunodiagnosis and radioimmunotherapy. Med Phys 1991;18:357–66.PubMedCrossRef
13.
Zurück zum Zitat Pentlow KS, Graham MC, Lambrecht RM, Daghighian F, Bacharach SL, Bendriem B, et al. Quantitative imaging of iodine-124 with PET. J Nucl Med 1996;37:1557–62.PubMed Pentlow KS, Graham MC, Lambrecht RM, Daghighian F, Bacharach SL, Bendriem B, et al. Quantitative imaging of iodine-124 with PET. J Nucl Med 1996;37:1557–62.PubMed
14.
Zurück zum Zitat Robinson S, Julyan PJ, Hastings DL, Zweit J. Performance of a block detector PET scanner in imaging non-pure positron emitters - modeling and experimental validation with I-124. Phys Med Biol 2004;49:5505–28.PubMedCrossRef Robinson S, Julyan PJ, Hastings DL, Zweit J. Performance of a block detector PET scanner in imaging non-pure positron emitters - modeling and experimental validation with I-124. Phys Med Biol 2004;49:5505–28.PubMedCrossRef
15.
Zurück zum Zitat Knust EJ, Dutschka K, Weinreich R. Preparation of I-124 solutions after thermodistillation of irradiated 124TeO2 targets. Appl Radiat Isot 2000;52:181–4.PubMedCrossRef Knust EJ, Dutschka K, Weinreich R. Preparation of I-124 solutions after thermodistillation of irradiated 124TeO2 targets. Appl Radiat Isot 2000;52:181–4.PubMedCrossRef
16.
Zurück zum Zitat Weinreich R, Knust EJ. Quality assurance of iodone-124 produced via the nuclear reaction 124Te(d, 2n)124I. J. Radioanal Nucl Chem Lett 1996;213:253–61.CrossRef Weinreich R, Knust EJ. Quality assurance of iodone-124 produced via the nuclear reaction 124Te(d, 2n)124I. J. Radioanal Nucl Chem Lett 1996;213:253–61.CrossRef
17.
Zurück zum Zitat Adam LE, Zaers J, Ostertag H, Trojan H, Bellemann ME, Brix G. Performance evaluation of the whole-body PET scanner ECAT EXACT HR+ following the IEC standard. IEEE Trans Nucl Sci 1997;44:1172–9.CrossRef Adam LE, Zaers J, Ostertag H, Trojan H, Bellemann ME, Brix G. Performance evaluation of the whole-body PET scanner ECAT EXACT HR+ following the IEC standard. IEEE Trans Nucl Sci 1997;44:1172–9.CrossRef
18.
Zurück zum Zitat Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000;41:1369–79.PubMed Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000;41:1369–79.PubMed
19.
Zurück zum Zitat DeGrado TR, Turkington TG, Williams JJ, Stearns CW, Hoffman JM, Coleman RE. Performance characteristics of a whole-body PET scanner. J Nucl Med 1994;35:1398–406.PubMed DeGrado TR, Turkington TG, Williams JJ, Stearns CW, Hoffman JM, Coleman RE. Performance characteristics of a whole-body PET scanner. J Nucl Med 1994;35:1398–406.PubMed
20.
Zurück zum Zitat Lewellen TK, Kohlmyer SG, Miyaoka RS, Kaplan MS, Stearns CW, Schubert SF. Investigation of the performance of the General Electric ADVANCE positron emission tomograph in 3D mode. IEEE Trans Nucl Sci 1996;43:2199–206.CrossRef Lewellen TK, Kohlmyer SG, Miyaoka RS, Kaplan MS, Stearns CW, Schubert SF. Investigation of the performance of the General Electric ADVANCE positron emission tomograph in 3D mode. IEEE Trans Nucl Sci 1996;43:2199–206.CrossRef
21.
Zurück zum Zitat Schötzig, U. und Schrader, H.: Halbwertszeiten und Photonen-Emissionswahrscheinlichkeiten von häufig verwendeten Radionukliden. PTB-Bericht PTB-Ra-16/5, Braunschweig, 2000. Schötzig, U. und Schrader, H.: Halbwertszeiten und Photonen-Emissionswahrscheinlichkeiten von häufig verwendeten Radionukliden. PTB-Bericht PTB-Ra-16/5, Braunschweig, 2000.
22.
Zurück zum Zitat National Electric Manufactures Association. NEMA Standards Publication NU 2-2001: Performance measurements of positron emission tomographs. 2001; 1–40. Rosslyn, VA, National Electric Manufactures Association. NEMA Standards Publication NU 2-2001.2001. National Electric Manufactures Association. NEMA Standards Publication NU 2-2001: Performance measurements of positron emission tomographs. 2001; 1–40. Rosslyn, VA, National Electric Manufactures Association. NEMA Standards Publication NU 2-2001.2001.
23.
Zurück zum Zitat International Standard IEC 61675-1: Radionuclide imaging devices - characteristics and test conditions - Part 1: Positron emission tomographs. International Eletrotechnical Commission. Geneva, 1998. International Standard IEC 61675-1: Radionuclide imaging devices - characteristics and test conditions - Part 1: Positron emission tomographs. International Eletrotechnical Commission. Geneva, 1998.
24.
Zurück zum Zitat Knoop BO, Geworski L, Hofmann M, Munz DL, Knapp WH. Use of recovery coefficients as a test of system linearity of response in positron emission tomography. Phys Med Biol 2002;47:1237–54.PubMedCrossRef Knoop BO, Geworski L, Hofmann M, Munz DL, Knapp WH. Use of recovery coefficients as a test of system linearity of response in positron emission tomography. Phys Med Biol 2002;47:1237–54.PubMedCrossRef
25.
Zurück zum Zitat Levin CS, Hoffman EJ. Calculation of positron range and its effect on the fundamental limit of positron emission tomography system spatial resolution. Phys Med Biol 1999;44:781–99.PubMedCrossRef Levin CS, Hoffman EJ. Calculation of positron range and its effect on the fundamental limit of positron emission tomography system spatial resolution. Phys Med Biol 1999;44:781–99.PubMedCrossRef
26.
Zurück zum Zitat Ramos CD, Erdi YE, Gonen M, Riedel E, Yeung HW, Macapinlac HA, et al. FDG-PET standardized uptake values in normal anatomical structures using iterative reconstruction segmented attenuation correction and filtered back-projection. Eur J Nucl Med 2001;28:155–64.PubMedCrossRef Ramos CD, Erdi YE, Gonen M, Riedel E, Yeung HW, Macapinlac HA, et al. FDG-PET standardized uptake values in normal anatomical structures using iterative reconstruction segmented attenuation correction and filtered back-projection. Eur J Nucl Med 2001;28:155–64.PubMedCrossRef
27.
Zurück zum Zitat Schoder H, Erdi YE, Chao K, Gonen M, Larson SM, Yeung HW. Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients. J Nucl Med 2004;45:559–66.PubMed Schoder H, Erdi YE, Chao K, Gonen M, Larson SM, Yeung HW. Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients. J Nucl Med 2004;45:559–66.PubMed
28.
Zurück zum Zitat Lubberink M, Schneider H, Bergstrom M, Lundqvist H. Quantitative imaging and correction for cascade gamma radiation of 76Br with 2D and 3D PET. Phys Med Biol 2002;47:3519–34.PubMedCrossRef Lubberink M, Schneider H, Bergstrom M, Lundqvist H. Quantitative imaging and correction for cascade gamma radiation of 76Br with 2D and 3D PET. Phys Med Biol 2002;47:3519–34.PubMedCrossRef
29.
Zurück zum Zitat Jentzen W, Schneider E, Freudenberg L, Eising EG, Gorges R, Muller SP, et al. Relationship between cumulative radiation dose and salivary gland uptake associated with radioiodine therapy of thyroid cancer. Nucl Med Commun 2006;27:669–76.PubMedCrossRef Jentzen W, Schneider E, Freudenberg L, Eising EG, Gorges R, Muller SP, et al. Relationship between cumulative radiation dose and salivary gland uptake associated with radioiodine therapy of thyroid cancer. Nucl Med Commun 2006;27:669–76.PubMedCrossRef
Metadaten
Titel
Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET(/CT) systems
verfasst von
Walter Jentzen
Reiner Weise
Jürgen Kupferschläger
Lutz Freudenberg
Wolfgang Brandau
Ronald Bares
Wolfgang Burchert
Andreas Bockisch
Publikationsdatum
01.03.2008
Verlag
Springer-Verlag
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 3/2008
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-007-0554-7

Weitere Artikel der Ausgabe 3/2008

European Journal of Nuclear Medicine and Molecular Imaging 3/2008 Zur Ausgabe